drugset / Trial / NCT00713336
Four-period Crossover Study to Assess the Effects of Single Oral Doses of ZD4054 (Zibotentan) (10mg and 30mg) on QTc Interval
RandomizedCrossoverTriple-blindBasic science
Summary
This Study compares two ZD4054 (Zibotentan) doses (10mg and 30mg) with a placebo and a positive control to look at ZD4054 (Zibotentan)'s effect on the ECG of Healthy Volunteer
Timeline
- Start
- 2008-06
- Primary completion
- —
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Zibotentan | Small molecule | 10 mg | — |
| Subject | Zibotentan | Small molecule | 30 mg | — |
Indications
No indication recorded.